Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
As we speak, on the fifth anniversary of his tragic demise, we're remembering Frank James Lee.
Named after his father and identified affectionately as...
Sporikova, Z., Koudelakova, V., Trojanec, R. & Hajduch, M. Genetic Markers in Triple-Detrimental Breast Most cancers. Clin Breast Most cancers 18, e841–e850 (2018).Article
...
